Ambur Vishnu, Taghavi Sharven, Jayarajan Senthil, Gaughan John, Toyoda Yoshiya, Dauer Elizabeth, Sjoholm Lars Ola, Pathak Abhijit, Santora Thomas, Goldberg Amy J
Temple University School of Medicine, Department of Surgery, Philadelphia, PA, USA.
Temple University School of Medicine, Biostatistics Consulting Center, Philadelphia, PA, USA.
Ann Med Surg (Lond). 2016 Mar 19;7:71-4. doi: 10.1016/j.amsu.2016.03.023. eCollection 2016 May.
Impaired wound healing due to immunosuppression has led some surgeons to preferentially use open gastrostomy tube (OGT) over percutaneous gastrostomy tube (PEG) in heart transplant patients when long-term enteral access is deemed necessary.
The National Inpatient Sample (NIS) database (2005-2010) was queried for all heart transplant patients. Those receiving OGT were compared to those treated with PEG tube.
There were 498 patients requiring long-term enteral access treated with a gastrostomy tube, with 424 (85.2%) receiving a PEG and 74 (14.8%) an OGT. The PEG cohort had higher Charlson comorbidity Index (4.1 vs. 2.0, p = 0.002) and a higher incidence of post-operative acute renal failure (31.5 vs. 12.7%, p = 0.001). Post-operative mortality was not different when comparing the two groups (13.8 vs. 6.1%, p = 0.06). On multivariate analysis, while both PEG (OR: 7.87, 95%C.I: 5.88-10.52, p < 0.001) and OGT (OR 5.87, 95%CI: 2.19-15.75, p < 0.001) were independently associated with mortality, PEG conferred a higher mortality risk.
This is the largest reported study to date comparing outcomes between PEG and OGT in heart transplant patients. PEG does not confer any advantage over OGT in this patient population with respect to morbidity, mortality, and length of stay.
由于免疫抑制导致伤口愈合受损,一些外科医生在认为有必要进行长期肠内营养通路时,更倾向于在心脏移植患者中使用开放式胃造口管(OGT)而非经皮胃造口管(PEG)。
查询国家住院患者样本(NIS)数据库(2005 - 2010年)中的所有心脏移植患者。将接受OGT的患者与接受PEG管治疗的患者进行比较。
有498例需要长期肠内营养通路的患者接受了胃造口管治疗,其中424例(85.2%)接受了PEG,74例(14.8%)接受了OGT。PEG组的查尔森合并症指数更高(4.1对2.0,p = 0.002),术后急性肾衰竭的发生率更高(31.5%对12.7%,p = 0.001)。两组术后死亡率无差异(13.8%对6.1%,p = 0.06)。多因素分析显示,虽然PEG(比值比:7.87,95%置信区间:5.88 - 10.52,p < 0.001)和OGT(比值比5.87,95%置信区间:2.19 - 15.75,p < 0.001)均与死亡率独立相关,但PEG的死亡风险更高。
这是迄今为止报道的比较心脏移植患者中PEG和OGT治疗效果的最大规模研究。在该患者群体中,PEG在发病率、死亡率和住院时间方面并不比OGT有任何优势。